High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.1M
$2,118,138
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
Other
|
2026-04-01 | $202,927 | M | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Donovan Joanne M.
• Officer • CMO
10b5-1 SellΔOwn -74.9%
2026-04-01
$926,095
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
10b5-1 SellΔOwn -74.9%
|
2026-04-01 | $926,095 | S | Form 4 |
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
Other
|
2026-03-31 | $151,073 | M | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Donovan Joanne M.
• Officer • CMO
10b5-1 SellΔOwn -69.0%
2026-03-31
$685,308
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
10b5-1 SellΔOwn -69.0%
|
2026-03-31 | $685,308 | S | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Donovan Joanne M.
• Officer • CMO
10b5-1 SellΔOwn -37.1%
2026-03-27
$506,735x2
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • CMO
10b5-1 SellΔOwn -37.1%
|
2026-03-27 | $506,735x2 | S | Form 4 |